Page last updated: 2024-09-03

ak 2123 and Breast Neoplasms

ak 2123 has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aibe, N; Kagiya, T; Kimoto, T; Kodani, N; Koizumi, M; Nakamura, S; Nishimura, T; Sihomi, H; Tsubokura, T; Yamazaki, H; Yoshida, K	1

Other Studies

1 other study(ies) available for ak 2123 and Breast Neoplasms

Article	Year
Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report. Anticancer research, 2013, Volume: 33, Issue:4 Topics: Administration, Oral; Adult; Aged; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Radiation-Sensitizing Agents; Radiosurgery; Triazoles	2013

Article

Year

Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report.

Anticancer research, 2013, Volume: 33, Issue:4

Topics: Administration, Oral; Adult; Aged; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Radiation-Sensitizing Agents; Radiosurgery; Triazoles

2013